| Dr Tracy Lynn Robinson-wood, LMHC | |
|
Robinson-wood Center For Applied Psych, 182 Windmill Road, Campton, NH 03223-4336 | |
| (603) 536-1902 | |
| (603) 536-1404 |
| Full Name | Dr Tracy Lynn Robinson-wood |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | Robinson-wood Center For Applied Psych, Campton, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700081650 | NPI | - | NPPES |
| 3096346 | Medicaid | NH |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tracy Lynn Robinson-wood, LMHC Robinson-wood Center For Applied Psych, 182 Windmill Road, Campton, NH 03223-4336 Ph: (603) 536-1902 | Dr Tracy Lynn Robinson-wood, LMHC Robinson-wood Center For Applied Psych, 182 Windmill Road, Campton, NH 03223-4336 Ph: (603) 536-1902 |
News Archive
The way the human brain works remains, to a great extent, a topic of controversy. One reason is our limited ability to study neuronal processes at the level of single cells and capillaries across the entire living brain without employing highly invasive surgical methods. This limitation is now on the brink of change.
In a new study in which Precision Therapeutics' Multi-Gene Predictors were independently validated by investigators at US Oncology and MD Anderson, Precision highlights the potential role of the ChemoFx® in vitro chemosensitivity test and multi-gene predictors in determining a patient's likelihood of response to multi-drug chemotherapy regimens in breast cancer.
Young children naturally like sugar and salt in food and develop food preferences based on what their parents serve them, but new research suggests that how parents view self-regulation also is a contributing factor.
Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.
SurModics IVD Inc., a wholly owned subsidiary of SurModics, Inc. and a market leader for in vitro diagnostic assay components, is pleased to announce it will launch BioFX TMB Extended Range HRP Microwell Substrate (TMBX) at the American Association for Clinical Chemistry show in Los Angeles, CA from July 17-19, 2012.
› Verified 7 days ago
Regina Gail Burtt, LCMHC, MLADC, SEP Counselor Medicare: Not Enrolled in Medicare Practice Location: 72 Susie Driscoll Road, Campton, NH 03223 Phone: 603-536-2271 | |
Gabriel Jose Vega, M.S., LCMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 11 South Mayd St, Campton, NH 03223 Phone: 603-412-2755 | |
Amy Dauphinais, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 Grand View Dr, Campton, NH 03223 Phone: 860-230-7474 |